Atlas Trials

A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

Clinical trial NCT02495844 · COMPLETED

Trial details

NCT number
NCT02495844
Sponsor
UCB Biopharma S.P.R.L.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Highly Drug-resistant Focal Epilepsy
Start date
2015-07-01
Primary completion
2017-02-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.